Two Sigma Securities’s Tandem Diabetes Care TNDM Stock Holding History

Two Sigma Securities’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,200	Closed	-$560K	–	3160
2024 Q3	$560K	Buy	13,200 +7,800	+144%	+$331K	0.01%	1239
2024 Q2	$218K	Sell	5,400 -9,600	-64%	-$401K	﹤0.01%	2286
2024 Q1	$531K	Sell	15,000 -800	-5%	-$21.4K	0.01%	1531
2023 Q4	$467K	Buy	+15,800	New	+$328K	﹤0.01%	1605
2023 Q2	–	Sell	-9,200	Closed	-$374K	–	3341
2023 Q1	$374K	Buy	9,200 +3,600	+64%	+$149K	0.01%	1487
2022 Q4	$252K	Sell	5,600 -5,400	-49%	-$244K	0.01%	1711
2022 Q3	$526K	Buy	+11,000	New	+$603K	0.02%	1063
2022 Q1	–	Sell	-3,000	Closed	-$452K	–	2511
2021 Q4	$452K	Buy	+3,000	New	+$405K	0.02%	585

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's TNDM Position: Q3 2024 in Review

Two Sigma Securities sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 34,572 shares — an estimated $1.47M sold.

Two Sigma Securities first reported a position in TNDM in Q3 2017 and held it in 8 quarters. The position peaked at $1.39M in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

Two Sigma Securities reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 34,572 Tandem Diabetes Care shares in Q3 2024, an estimated $1.47M.
Two Sigma Securities first reported a position in Tandem Diabetes Care in Q3 2017 and held it in 8 quarters.
Two Sigma Securities's Tandem Diabetes Care position peaked at $1.39M in Q2 2024.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.